THOMAS TAYLOR to Aged, 80 and over
This is a "connection" page, showing publications THOMAS TAYLOR has written about Aged, 80 and over.
Connection Strength
0.033
-
Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One. 2022; 17(2):e0263591.
Score: 0.020
-
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015 Mar; 15(3):301-9.
Score: 0.013